DaviesTF. Thyroid eye disease: A new name, a new guide, and a new era. Thyroid, 2022; 32(12):1434–1436. doi: 10.1089/thy.2022.0628
2.
PritchardJ, HanR, HorstN, et al.Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J. Immunol, 2003; 170(12):6348–6354; doi: 10.4049/jimmunol.170.12.6348
3.
DouglasRS, GianoukakisAG, KamatS, et al.Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J Immunol, 2007; 178(5):3281–3287; doi: 10.4049/jimmunol.178.5.3281
4.
TsuiS, NaikV, HoaN, et al.Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: A tale of two antigens implicated in Graves' disease. J Immunol, 2008; 181(6):4397–4405; doi: 10.4049/jimmunol.181.6.4397
5.
SmithTJ, HoaN. Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. J Clin Endocrinol Metab, 2004; 89(10):5076–5080; doi: 10.1210/jc.2004-0716
